Monday, 23 April 2018

Jilted Akorn sues Fresenius over deal termination

FRANKFURT (Reuters) - U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)